Advisory Board August 22, 2024
As GLP-1 weight-loss drugs continue to grow in popularity, some hospitals and health systems are scaling back on bariatric surgeries and rethinking their investments in certain areas of care.
4 ways comprehensive obesity care can boost surgical services
How weight-loss drugs are affecting bariatric services
According to a poll from KFF, around one in eight American adults, or about 15 million people, say they’ve taken a GLP-1 — a number that could grow if more insurers decide to cover the drugs for weight loss. Currently, an estimate from J.P. Morgan projects that as many as 30 million Americans could be taking GLP-1 drugs by 2030.
As GLP-1 drugs continue to grow in popularity, there has been a decline in...
Today's Sponsors
Today's Sponsor